跳至主要内容
临床试验/EUCTR2008-005307-26-IT
EUCTR2008-005307-26-IT进行中(未招募)1 期

Intratecal Ziconotide in the treatment of neuropatic pain in cancer patients.A phase II study. - ZIDO

ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE0 个研究点目标入组 16 人开始时间: 2009年6月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Diagnosis of malignant tumors; 2. Severe neuropatic pain (VASPI 6 or greater); 3.Pain not responsive to opioids and adjuvant drugs; 4. Age 18 or greater; 5.Performance Status 0-2; Life expectancy greater than 1 month; effective contraception in female patients if the risk of conception exists; 8. Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Exposure to experimental drugs in the previous 30 days; 2.Nursing and/or pregnant women; 3. Contraindication of intratecal analgesia (including active infections or disorders in liquor circulation); 4.Brain metastases; 5.INR greater than 2; 6.Contraindication of ziconotide use; 7.Incapacity or refusal to sign the informed consent

研究者

发起方
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE

相似试验